Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (4144)	2/19/1998 1:59:00 AM
From: Troll_29	Read Replies (1) \| Respond to of 9719

V1: Diacrin -- is this too long term? They are partly owned by Genzyme, have been discussed favorably many places and seem to be progressing with respect to research. IBD called the market they seek with the porcine fetal cells in excess of 1 billion. I am long. Only thing I note to dislike is stock price (unfortunately). Do you have additional views with respect to their future potential? Appreciate any comments. Troll